Engineers Gate Manager’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
SCM
TCM
GACM
Engineers Gate Manager's ANIP Position: Q2 2026 in Review
Engineers Gate Manager reduced its ANI Pharmaceuticals (ANIP) stake by 6.4% in Q2 2026, selling an estimated $81.7K and leaving 14,979 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #958.
Engineers Gate Manager first reported a position in ANIP in Q2 2018 and has held it in 13 quarters since. The position peaked at $1.63M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Engineers Gate Manager held 14,979 shares of ANI Pharmaceuticals worth $1.24M as of Q2 2026.
- Engineers Gate Manager sold 1,018 ANI Pharmaceuticals shares in Q2 2026, an estimated $81.7K.
- ANI Pharmaceuticals made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #958 holding.
- Engineers Gate Manager first reported a position in ANI Pharmaceuticals in Q2 2018 and has held it in 13 quarters since.
- Engineers Gate Manager's ANI Pharmaceuticals position peaked at $1.63M in Q4 2025.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.